Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Magdalena Biosciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Magdalena Biosciences

Magdalena Biosciences

Dover-based Magdalena Biosciences creates plant-derived prescription medicines for adult ADHD.

HQ
Dover, DE, US
Founded
2023
Overview
Compare
Fundraising
Employees

Magdalena Biosciences, based in Dover, Delaware, focuses on developing novel, plant-derived prescription medicines for mental health, specifically targeting adult ADHD. Their mission is to harness natural compounds to provide effective and safe treatment options for mental health conditions.

The company has made significant strides in the mental health sector by innovating natural alternatives to traditional medications. Their impact is seen in the growing acceptance and use of plant-based treatments for ADHD, contributing to a broader understanding and adoption of natural medicine in mental health care.

Magdalena Biosciences - Similar Companies

Sensorium Therapeutics logo

Sensorium Therapeutics

sensorium.bio

Zena Therapeutics logo

Zena Therapeutics

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Mojave Pharma logo

Mojave Pharma

Mavida Health logo

Mavida Health

mavidahealth.com

Mahzi Therapeutics logo

Mahzi Therapeutics

mahzi.com

Magna Pharmaceuticals logo

Magna Pharmaceuticals

magnaweb.com

Mentavi logo

Mentavi

mentavi.com

MindSet Rx logo

MindSet Rx

Agave Health logo

Agave Health

agavehealth.com

Woven Science logo

Woven Science

woven.science

Mimosa Therapeutics logo

Mimosa Therapeutics

Maya Health logo

Maya Health

MentiNova logo

MentiNova

BioHealthonomics logo

BioHealthonomics

Magdalena Biosciences - Quick Facts

Who are Magdalena Biosciences' competitors?

Companies similar to Magdalena Biosciences include Sensorium Therapeutics, Zena Therapeutics, Reset Pharmaceuticals and Mojave Pharma.

When was Magdalena Biosciences founded?

Magdalena Biosciences was founded in 2023.

Where is Magdalena Biosciences' headquarters located?

Magdalena Biosciences' headquarters is located in Dover, DE, US.

When was Magdalena Biosciences' last funding round?

Magdalena Biosciences' most recent funding round was for $1M (USD) in January 2023.

How much has Magdalena Biosciences raised to-date?

As of Jan 10, 2023, Magdalena Biosciences has raised a total of $1M (USD).

How many employees does Magdalena Biosciences have?

Magdalena Biosciences has 5 employees as of Feb 4, 2024.

Magdalena Biosciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Prescription Medicines
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified